Medipace is a California-based medical device company developing a sacral nerve stimulation therapy for patients with ulcerative colitis.

We are presently recruiting clinical sites for our early-feasibility study in the US.

Our first-in-human clinical study is nearly completed, the results will be posted on ClinicalTrials.gov

We are supported by funding from the National Institutes of Health